Javascript must be enabled to continue!
Microbiota and Immune Regulation in Lung Transplantation
View through CrossRef
Abstract
Purpose of the Review
The lung and gut microbiomes have been associated with many important patient-centered outcomes in respiratory diseases, and these have been further associated with pulmonary immunity. Lung transplant patients are necessarily unique with regards to their microbiome characteristics and their immune responses. The goal of this review is to summarize the emerging literature relevant to of bidirectional relationship of the microbiome and pulmonary immunity, with a focus on data relevant to lung transplant recipients.
Recent Findings
Lung transplant patients tend to have increased lung bacterial burden and shifts in microbial community composition relative to healthy controls. These lung microbiome changes are linked to important post-transplant outcomes, including primary graft dysfunction, acute rejection, and chronic lung allograft dysfunction. Furthermore, these lung microbiome characteristics—especially having an increased lung bacterial burden or communities dominated by “pathogenic” taxa are associated with a pro-inflammatory pulmonary immune signals in lung transplant patients, despite their concurrent use of immunosuppression. The gut microbiome, through systemic pathways such as short-chain fatty acid (SCFA) production, also appears to influence pulmonary immunity in non-transplant patients, although its role in lung transplant recipients remains underexplored.
Summary
The lung microbiome remains an important factor in pulmonary immunity after lung transplantation, and the gut microbiome has been implicated as further impacting pulmonary and systemic immunity in non-transplant population. Microbiome-targeted interventions show promise—especially in selected populations—but have not yet been linked with improved patient-centered outcomes. Further research which incorporates adequate clinical context is needed to disentangle which microbiome features and immune signals might be harnessed or targeted to optimize post-transplant care and prolong allograft survival.
Title: Microbiota and Immune Regulation in Lung Transplantation
Description:
Abstract
Purpose of the Review
The lung and gut microbiomes have been associated with many important patient-centered outcomes in respiratory diseases, and these have been further associated with pulmonary immunity.
Lung transplant patients are necessarily unique with regards to their microbiome characteristics and their immune responses.
The goal of this review is to summarize the emerging literature relevant to of bidirectional relationship of the microbiome and pulmonary immunity, with a focus on data relevant to lung transplant recipients.
Recent Findings
Lung transplant patients tend to have increased lung bacterial burden and shifts in microbial community composition relative to healthy controls.
These lung microbiome changes are linked to important post-transplant outcomes, including primary graft dysfunction, acute rejection, and chronic lung allograft dysfunction.
Furthermore, these lung microbiome characteristics—especially having an increased lung bacterial burden or communities dominated by “pathogenic” taxa are associated with a pro-inflammatory pulmonary immune signals in lung transplant patients, despite their concurrent use of immunosuppression.
The gut microbiome, through systemic pathways such as short-chain fatty acid (SCFA) production, also appears to influence pulmonary immunity in non-transplant patients, although its role in lung transplant recipients remains underexplored.
Summary
The lung microbiome remains an important factor in pulmonary immunity after lung transplantation, and the gut microbiome has been implicated as further impacting pulmonary and systemic immunity in non-transplant population.
Microbiome-targeted interventions show promise—especially in selected populations—but have not yet been linked with improved patient-centered outcomes.
Further research which incorporates adequate clinical context is needed to disentangle which microbiome features and immune signals might be harnessed or targeted to optimize post-transplant care and prolong allograft survival.
Related Results
IMPACT OF GUT MICROBIOTA ON POSTOPERATIVE RECOVERY AND WOUND HEALING
IMPACT OF GUT MICROBIOTA ON POSTOPERATIVE RECOVERY AND WOUND HEALING
The gut microbiota, made up of trillions of microorganisms that inhabit the gastrointestinal tract, plays a fundamental role in human health, influencing immunological and metaboli...
The Microbiota and Microbiome in COVID-19 in Adults and Children and Potential Therapeutic Interventions: A Review
The Microbiota and Microbiome in COVID-19 in Adults and Children and Potential Therapeutic Interventions: A Review
The work presented is a comprehensive review of the role of the human microbiota in the context of the COVID-19 pandemic. A diverse microbial community heavily colonizes the human ...
Monitoring oral microbiota-virus associations as biomarkers of immune resistance
Monitoring oral microbiota-virus associations as biomarkers of immune resistance
Relevance. The oral microbiota, including its interactions with viruses, plays a crucial role in an individual's immune system. Investigating these microbiota-virus associations as...
Blood usage in lung transplantation
Blood usage in lung transplantation
BACKGROUND: Few published data are available regarding perioperative blood usage in lung transplantation. STUDY DESIGN AND METHODS: The medical records of all patients undergoing l...
Circadian disruption and divergent microbiota acquisition under extended photoperiod regimens in chicken
Circadian disruption and divergent microbiota acquisition under extended photoperiod regimens in chicken
The gut microbiota is crucial for metabolic homeostasis, immunity, growth and overall health, and it recognized that early-life microbiota acquisition is a pivotal event for later ...
Vaginal microbiota and preterm birth
Vaginal microbiota and preterm birth
Vaginal microbiota composition is associated with spontaneous preterm birth (sPTB), depending on ethnicity. Host-microbiota interactions are thought to play an important underlying...
Mahuang Fuzi Xixin decoction ameliorates allergic rhinitis and repairs the airway epithelial barrier by modulating the lung microbiota dysbiosis
Mahuang Fuzi Xixin decoction ameliorates allergic rhinitis and repairs the airway epithelial barrier by modulating the lung microbiota dysbiosis
BackgroundAllergic rhinitis (AR) is a common disorder, that burdens general well-being. Although the lung is connected to the upper respiratory tract, which is rich in microorganis...
EPD Electronic Pathogen Detection v1
EPD Electronic Pathogen Detection v1
Electronic pathogen detection (EPD) is a non - invasive, rapid, affordable, point- of- care test, for Covid 19 resulting from infection with SARS-CoV-2 virus. EPD scanning techno...

